Seattle Genetics Inc (SGEN): Baker Bros. Advisors Raises Stake

Page 12 of 16

Page 12 of 16 – SEC Filing
667, L.P. 9/13/2016 2,445  Purchase         50.4214 26
Baker Brothers Life Sciences, L.P. 9/13/2016 21,804  Purchase         50.4214 26
667, L.P. 9/13/2016 101  Purchase         50.6370 27
Baker Brothers Life Sciences, L.P. 9/13/2016 899  Purchase         50.6370 27
667, L.P. 9/13/2016 6,565  Purchase         51.4057 28
Baker Brothers Life Sciences, L.P. 9/13/2016 58,541  Purchase         51.4057 28
667, L.P. 9/13/2016 2,730  Purchase         51.5457 29
Baker Brothers Life Sciences, L.P. 9/13/2016 24,339  Purchase         51.5457 29

(1) The reported price is a weighted average price. These shares
were traded in multiple transactions at a prices ranging from $45.40 to $46.00. The Reporting Persons undertake to provide the
Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the “Staff”), upon
request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.

 (2) The reported price is a weighted
average price. These shares were traded in multiple transactions at prices ranging from $44.83 to $45.00. The Reporting Persons
undertake to provide the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the
number of shares traded at each separate price within the ranges set forth in this footnote.

 (3) The reported price is a weighted
average price. These shares were traded in multiple transactions at prices ranging from $46.02 to $46.15. The Reporting Persons
undertake to provide the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the
number of shares traded at each separate price within the ranges set forth in this footnote.

 (4) The reported price is a weighted
average price. These shares were traded in multiple transactions at prices ranging from $45.18 to $46.15. The Reporting Persons
undertake to provide the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the
number of shares traded at each separate price within the ranges set forth in this footnote.

 (5) The reported price is a weighted
average price. These shares were traded in multiple transactions at prices ranging from $45.00 to $45.15. The Reporting Persons
undertake to provide the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the
number of shares traded at each separate price within the ranges set forth in this footnote.

 (6) The reported price is a weighted
average price. These shares were traded in multiple transactions at prices ranging from $46.00 to $46.25. The Reporting Persons
undertake to provide the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the
number of shares traded at each separate price within the ranges set forth in this footnote.

(7) The reported price is a weighted average price. These shares
were traded in multiple transactions at prices ranging from $48.21 to $48.35. The Reporting Persons undertake to provide the Issuer,
any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares traded at each separate
price within the ranges set forth in this footnote.

Page 12 of 16

Follow Seagen Inc. (NASDAQ:SGEN)

Page 12 of 16